Literature DB >> 3048094

Epidemiology of hypertension in older patients.

W M Smith1.   

Abstract

There are few studies devoted specifically to the epidemiology of older hypertensive patients, although some information has been obtained from broader trials in which either the study populations have become older or an older subgroup has been identified. Three areas have been addressed: the changes of blood pressure with age; the prevalence of hypertension in older persons; and the risks of elevated blood pressure in elderly patients. It has been found that blood pressure, especially systolic pressure, increases with age. Consequently, hypertension is extremely prevalent in this age group, affecting 65 percent or more of those over 65 years old, and the phenomenon of isolated systolic hypertension is common. Whereas in the past many physicians treating the elderly have regarded hypertension in these patients as normal and acceptable, or even helpful in ensuring adequate organ perfusion, elevated blood pressure in the elderly is far from benign. Older hypertensive patients' risks of cardiovascular complications and death are from two to five times that of normotensive persons. Treatment of diastolic hypertension in older patients can be expected to delay the onset of cardiovascular disease and improve the quality of life. Hopefully, this will prove to be true for isolated systolic hypertension as well.

Entities:  

Mesh:

Year:  1988        PMID: 3048094     DOI: 10.1016/0002-9343(88)90342-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  3 in total

Review 1.  Perspective on hypertension in the elderly.

Authors:  B Whitcomb; R L Byyny
Journal:  West J Med       Date:  1990-04

Review 2.  Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.

Authors:  H D Langtry; A Markham
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

Review 3.  Choosing the right ACE inhibitor. A guide to selection.

Authors:  G Leonetti; C Cuspidi
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.